One key area of interest in cardiovascular endocrinology is the impact of metabolic syndrome on cardiovascular health. Metabolic syndrome, characterized by a cluster of conditions such as obesity, insulin resistance, and dyslipidemia, significantly increases the risk of cardiovascular diseases. Cardiovascular endocrinologists study the intricate relationships between adipose tissue, insulin signaling, and inflammation, exploring how these factors contribute to the development of atherosclerosis and cardiovascular complications. Research in cardiovascular endocrinology also delves into hormonal regulation of blood pressure, focusing on the role of aldosterone, renin-angiotensin-aldosterone system (RAAS), and other hormones in maintaining cardiovascular homeostasis. The integration of endocrinology and cardiovascular medicine highlights the need for a comprehensive understanding of the interactions between hormonal regulation and cardiovascular function, paving the way for targeted therapies and personalized approaches to address the multifaceted aspects of cardiovascular health.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation